Evidence map›Paper›PMID 39231991›Full record

ArticleNature communications2024

Structures of the Mycobacterium tuberculosis efflux pump EfpA reveal the mechanisms of transport and inhibition.

Shuhui Wang, Kun Wang, Kangkang Song, Zon Weng Lai, Pengfei Li, Dongying Li, Yajie Sun, Ye Mei, Chen Xu, Maofu Liao

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Structural basis of G6P/Pi transport and inhibition in SLC37A4.Nature structural & molecular biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Structure and function ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Shuhui WangDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA. shuhui.wang@yale.edu.ORCID 0000-0002-2393-9518
Kun WangDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Kangkang SongDepartment of Biochemistry & Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Zon Weng LaiDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Pengfei LiSingle Particle, LLC, San Diego, CA, USA.
Dongying LiDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Yajie SunCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ye MeiState Key Laboratory of Precision Spectroscopy, School of Physics and Electronic Science, East China Normal University, Shanghai, China.ORCID 0000-0002-3953-8508
Chen XuDepartment of Biochemistry & Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Maofu LiaoDepartment of Chemical Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China. liaomf@sustech.edu.cn.ORCID 0000-0002-3481-450X

Funding

Pacific Northwest Center for Cryo-EM - Screening supplementU24GM129547 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI EVANS, JAMES E, GOUAUX, JAMES E · 2018 to 2023
$54.8M
National Natural Science Foundation of China (National Science Foundation of China) 32330054NIGMS NIH HHS U24 GM129547
6 · The paper itself

Abstract

As the first identified multidrug efflux pump in Mycobacterium tuberculosis (Mtb), EfpA is an essential protein and promising drug target. However, the functional and inhibitory mechanisms of EfpA are poorly understood. Here we report cryo-EM structures of EfpA in outward-open conformation, either bound to three endogenous lipids or the inhibitor BRD-8000.3. Three lipids inside EfpA span from the inner leaflet to the outer leaflet of the membrane. BRD-8000.3 occupies one lipid site at the level of inner membrane leaflet, competitively inhibiting lipid binding. EfpA resembles the related lysophospholipid transporter MFSD2A in both overall structure and lipid binding sites and may function as a lipid flippase. Combining AlphaFold-predicted EfpA structure, which is inward-open, we propose a complete conformational transition cycle for EfpA. Together, our results provide a structural and mechanistic foundation to comprehend EfpA function and develop EfpA-targeting anti-TB drugs.

Indexed as

Bacterial ProteinsMycobacterium tuberculosisAntitubercular AgentsBinding SitesBiological TransportCryoelectron MicroscopyMembrane Transport ProteinsModels, MolecularProtein ConformationAntitubercular AgentsBacterial ProteinsMembrane Transport Proteins

Identifiers

PMID39231991
PMCPMC11375168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.